Clinical Trials Directory

Trials / Completed

CompletedNCT01075256

Dose Response of a Tubule Occlusion Agent

An Exploratory Clinical Study to Evaluate the Efficacy of Two Currently Marketed Toothpastes Containing Different Concentrations of a Tubule Occlusion Agent

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
195 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy of two different concentrations of a tubule occlusion agent - calcium sodium phosphosilicate in treatment of dentine hypersensitivity

Detailed description

Dentine hypersensitivity is characterized by short, sharp pain arising from exposed dentine typically in response to chemical, thermal, tactile or osmotic stimuli. Dentine hypersensitivity may be treated by either making the nerve in the tooth less sensitive or by occluding the tubules to limit exposure of the nerve to external stimuli. Bioactive and biocompatible glasses react with oral fluid to deposit a mineral that is chemically analogous to that found in both enamel and dentine thus preventing exposure of the nerve to external stimuli. A number of controlled clinical trials have been reported indicating that a calcium sodium phosphosilicate bioactive glass, when incorporated into a toothpaste formulation, significantly reduce pain from dentine hypersensitivity. The aim of this study is to evaluate the effectiveness of two currently marketed toothpastes, containing 5% calcium sodium phosphosilicate and the other containing 7.5% calcium sodium phosphosilicate in the treatment of dentine hypersensitivity compared to a matched placebo control.

Conditions

Interventions

TypeNameDescription
DEVICE5% calcium sodium phosphosilicate toothpasteLow concentration calcium sodium phosphosilicate tubule occlusion agent
DEVICE7.5% calcium sodium phosphosilicate toothpasteHigh concentration calcium sodium phosphosilicate tubule occlusion agent
DEVICEPlacebo toothpastePlacebo toothpaste

Timeline

Start date
2008-12-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2010-02-25
Last updated
2013-06-03
Results posted
2013-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01075256. Inclusion in this directory is not an endorsement.